XOMAP Q1 2018 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$463,000+78.1% YoY

Gross Profit

$31,0006.7% margin

Operating Income

-$5M-1109.5% margin

Net Income

-$4M-822.0% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-91.4%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$43M

Total Liabilities

$38M

Stockholders' Equity

$6M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$463,000	$260,000	+78.1%
Gross Profit	$31,000	-$4M	+100.8%
Operating Income	-$5M	-$11M	+53.0%
Net Income	-$4M	-$11M	+64.5%